These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9399015)

  • 21. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zolmitriptan provides consistent migraine relief when used in the long-term.
    Tuchman M; Edvinsson L; Geraud G; Korczyn A; Mauskop A; Pfaffenrath V
    Curr Med Res Opin; 1999; 15(4):272-81. PubMed ID: 10640259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long-term study to maximise migraine relief with zolmitriptan.
    Tepper SJ; Donnan GA; Dowson AJ; Bomhof MA; Elkind A; Meloche J; Fletcher PE; Millson DS
    Curr Med Res Opin; 1999; 15(4):254-71. PubMed ID: 10640258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 311C90, a new central and peripherally acting 5-HT1D receptor agonist in the acute oral treatment of migraine: a double-blind, placebo-controlled, dose-range finding study.
    Visser WH; Klein KB; Cox RC; Jones D; Ferrari MD
    Neurology; 1996 Feb; 46(2):522-6. PubMed ID: 8614525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 311C90: patient profiles and typical case histories of migraine management.
    Dowson AJ
    Neurology; 1997 Mar; 48(3 Suppl 3):S29-33. PubMed ID: 9071268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute management of migraine: triptans and beyond.
    Diener HC; Limmroth V
    Curr Opin Neurol; 1999 Jun; 12(3):261-7. PubMed ID: 10499171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical effectiveness of 311C90 in the acute treatment of migraine.
    Ferrari MD
    Eur Neurol; 1996; 36 Suppl 2():4-7. PubMed ID: 8791025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study.
    Gruffyd-Jones K; Kies B; Middleton A; Mulder LJ; Røsjø Ø; Millson DS
    Eur J Neurol; 2001 May; 8(3):237-45. PubMed ID: 11328332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
    Geraud G; Compagnon A; Rossi A;
    Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.
    Loder E; Silberstein SD; Abu-Shakra S; Mueller L; Smith T
    Headache; 2004 Feb; 44(2):120-30. PubMed ID: 14756849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
    Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
    Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zolmitriptan: differences from sumatriptan.
    Goadsby PJ; Boes CJ
    Curr Med Res Opin; 2001; 17 Suppl 1():s46-50. PubMed ID: 12463277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
    Ho TW; Ferrari MD; Dodick DW; Galet V; Kost J; Fan X; Leibensperger H; Froman S; Assaid C; Lines C; Koppen H; Winner PK
    Lancet; 2008 Dec; 372(9656):2115-23. PubMed ID: 19036425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the long-term safety and efficacy of 311C90 in the treatment of migraine.
    Geraud GE
    Eur Neurol; 1996; 36 Suppl 2():24-7. PubMed ID: 8791029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can oral 311C90, a novel 5-HT1D agonist, prevent migraine headache when taken during an aura?
    Dowson A
    Eur Neurol; 1996; 36 Suppl 2():28-31. PubMed ID: 8791030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial.
    Mathew NT; Kailasam J; Gentry P; Chernyshev O
    Headache; 2000 Jun; 40(6):464-5. PubMed ID: 10849042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zolmitriptan Nasal Spray: A Review in Acute Migraine in Pediatric Patients 12 Years of Age or Older.
    McKeage K
    Paediatr Drugs; 2016 Feb; 18(1):75-81. PubMed ID: 26747634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose-response study.
    Sakai F; Iwata M; Tashiro K; Itoyama Y; Tsuji S; Fukuuchi Y; Sobue G; Nakashima K; Morimatsu M
    Cephalalgia; 2002 Jun; 22(5):376-83. PubMed ID: 12110113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group.
    Pascual J; Vega P; Diener HC; Allen C; Vrijens F; Patel K
    Cephalalgia; 2000 Jun; 20(5):455-61. PubMed ID: 11037741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.